Clinical Research Directory
Browse clinical research sites, groups, and studies.
Psilocybin Therapy for Depression in Bipolar II Disorder
Sponsor: University of California, San Francisco
Summary
The purpose of this study is to determine the safety, tolerability, and feasibility of psilocybin therapy in people with Bipolar II Disorder.
Official title: An Open-Label Pilot Study Examining the Feasibility, Safety, and Effectiveness of Psilocybin Therapy for Depression in Bipolar II Disorder
Key Details
Gender
All
Age Range
18 Years - 70 Years
Study Type
INTERVENTIONAL
Enrollment
14
Start Date
2022-01-28
Completion Date
2025-07
Last Updated
2024-09-25
Healthy Volunteers
No
Conditions
Interventions
Psilocybin therapy
\- Psilocybin administration session 10mg-25mg delivered orally with psychological support and monitoring
Locations (1)
University of California, San Francisco
San Francisco, California, United States